Copyright
©The Author(s) 2020.
World J Gastroenterol. Jan 14, 2020; 26(2): 168-183
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.168
Published online Jan 14, 2020. doi: 10.3748/wjg.v26.i2.168
Figure 3 Serum LncRNAs and mRNA as prognostic biomarker for hepatitis C virus treated patients with different treatment reginens.
ROC curve analysis for SOF + SIM (A), SOF + DAC (B), and SOF + DAC + RBV (C) as prognostic biomarkers discriminate treated from naïve patients. 1st LncRNA gas 5; 2nd LncRNA BISPR; 3rd LncRNA HEIH; 4th mRNA BST2.
- Citation: El Samaloty NM, Shabayek MI, Ghait RS, El-Maraghy SA, Rizk SM, El-Sawalhi MM. Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4. World J Gastroenterol 2020; 26(2): 168-183
- URL: https://www.wjgnet.com/1007-9327/full/v26/i2/168.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i2.168